Efeito da lavagem peritoneal com bupivacaína na sobrevida de ratos com peritonite fecal


Autoria(s): Brocco, Marcos Célio; Paulo, Danilo Nagib Salomão; Baptista, João Florêncio de Abreu; Carraretto, Antônio Roberto; Ferrari, Thiago Antunes; De Azevedo, Thiago Caetano V.; Da Silva, Alcino Lázaro
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

01/09/2008

Resumo

BACKGROUND AND OBJECTIVES: Based on the knowledge of the anti-inflammatory and anti-bacterial actions of local anesthetics (LA), the objective of this study was to determine the effects of peritoneal lavage with bupivacaine on survival of mice with fecal peritonitis. METHODS: Forty-eight Wistar mice, weighing between 300 and 330 g (311.45 ± 9.67 g), undergoing laparotomy 6 hours after induction of peritonitis were randomly divided in 4 groups: 1 - Control, without treatment (n = 12); 2 - Drying of the abdominal cavity (n = 12); 3 - Lavage with 3 mL NS and posterior drying of the abdominal cavity (n = 12); and 4 - Lavage with 8 mg.kg -1 (± 0.5 mL) of 0.5% bupivacaine added to 2.5 mL of NS followed by drying out of the abdominal cavity (n = 12). Animals that died underwent necropsy and the time of death was recorded. Surviving animals were killed on the 11 th postoperative day and underwent necropsy. RESULTS: Group 1 presented a 100% mortality rate in 52 hours, 100% mortality rate in Group 2 in 126 hours, and Group 3 presented a 50% mortality rate in 50 hours. Animals in Group 4 survived. Survival on the 11 th day was greater in groups 3 and 4 than in Groups 1 and 2 (p < 0.001) and greater in Group 4 than in Group 3 (p < 0.01). CONCLUSIONS: Peritoneal lavage with a solution of bupivacaine diluted in NS was effective in preventing death for 11 days in 100% of animals with fecal peritonitis. © Sociedade Brasileira de Anestesiologia, 2008.

Formato

470-479

Identificador

http://dx.doi.org/10.1590/S0034-70942008000500005

Revista Brasileira de Anestesiologia, v. 58, n. 5, p. 470-479, 2008.

0034-7094

1806-907X

http://hdl.handle.net/11449/70545

10.1590/S0034-70942008000500005

S0034-70942008000500005

2-s2.0-52249109828

2-s2.0-52249109828.pdf

Idioma(s)

por

Relação

Revista Brasileira de Anestesiologia

Direitos

openAccess

Palavras-Chave #Anesthetic, local: Bupivacaine #Animals: Mice #Complications, infection: Peritonitis #amikacin #aminoglycoside antibiotic agent #amoxicillin plus clavulanic acid #ampicillin #antibiotic agent #bupivacaine #cefazolin #ceftriaxone #cephalosporin derivative #ciprofloxacin #clindamycin #cotrimoxazole #erythromycin #gatifloxacin #gentamicin #ketamine #levofloxacin #lidocaine #linezolid #local anesthetic agent #nitrofurantoin #norfloxacin #oxacillin #penicillin derivative #quinoline derived antiinfective agent #rifampicin #ropivacaine #sultamicillin #unindexed drug #vancomycin #animal experiment #animal model #antibacterial activity #antibiotic sensitivity #antiinflammatory activity #controlled study #drug effect #feces #Gram negative bacterium #Gram positive bacterium #immune response #laparotomy #mortality #mouse #nonhuman #peritoneal cavity #peritoneum lavage #peritonitis #sepsis #survival rate
Tipo

info:eu-repo/semantics/article